Cargando…
Impact of COVID-19 on Patients with Inflammatory Bowel Disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China, in late 2019. Responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, SARS-CoV-2 is one of three structurally similar beta-coronaviruses that can cause a strong upregulation of cytoki...
Autores principales: | Ambrose, Paula A., Goodman, Wendy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373928/ https://www.ncbi.nlm.nih.gov/pubmed/35966234 http://dx.doi.org/10.14218/jerp.2021.00014 |
Ejemplares similares
-
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021) -
Impact of COVID-19 in Pediatric Patients and Young Adults with Inflammatory Bowel Disease
por: Magalhães, Tiago, et al.
Publicado: (2022) -
COVID-19 and Inflammatory Bowel Disease
por: Summa, Keith C., et al.
Publicado: (2023) -
Impact of the Lockdown Due to the COVID-19 Pandemic on Patients With Inflammatory Bowel Disease
por: Nishida, Yu, et al.
Publicado: (2021) -
The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)